(Q37451495)

20 August 2017

1 reference

title

Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease (English)

1 reference

20 August 2017

main subject

cardiovascular disease

1 reference

1 reference

3

Maarten L Simoons

1 reference

20 August 2017

Jasper J Brugts

1

1 reference

20 August 2017

Roberto Ferrari

series ordinal

2

1 reference

20 August 2017

publication date

1 April 2009

1 reference

Expert Review of Cardiovascular Therapy

20 August 2017

published in

1 reference

20 August 2017

volume

7

1 reference

20 August 2017

issue

4

1 reference

20 August 2017

page(s)

345-360

1 reference

The biochemistry of the renin-angiotensin system and its role in hypertension

20 August 2017

cites work

1 reference

Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis K. Dahl memorial lecture

21 January 2018

1 reference

Renin-angiotensin-aldosterone system: fundamental aspects and clinical implications in renal and cardiovascular disorders

21 January 2018

1 reference

Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease

21 January 2018

1 reference

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

21 January 2018

1 reference

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

Angiotensin-converting-enzyme inhibition in stable coronary artery disease

21 January 2018

1 reference

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

21 January 2018

1 reference

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology

21 January 2018

1 reference

Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology

21 January 2018

1 reference

ACC/AHA 2002 guideline update for the management of patients with chronic stable angina--summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Pat

21 January 2018

1 reference

Specific properties and effect of perindopril in controlling the renin-angiotensin system

21 January 2018

1 reference

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

21 January 2018

1 reference

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

21 January 2018

1 reference

Perindopril postmarketing surveillance: a 12 month study in 47,351 hypertensive patients

21 January 2018

1 reference

ACE inhibition and endothelial function: main findings of PERFECT, a sub-study of the EUROPA trial

21 January 2018

1 reference

Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study)

21 January 2018

1 reference

Angiotensin-Converting Enzyme Inhibitors

21 January 2018

1 reference

Perindopril arginine: benefits of a new salt of the ACE inhibitor perindopril

21 January 2018

1 reference

Sodium-lithium countertransport: physiology and function

21 January 2018

1 reference

Angiotensin receptors and their antagonists

21 January 2018

1 reference

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

21 January 2018

1 reference

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril

21 January 2018

1 reference

21 January 2018

1 reference

Pharmacokinetic-pharmacodynamic model for perindoprilat regional haemodynamic effects in healthy volunteers and in congestive heart failure patients

21 January 2018

1 reference

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

21 January 2018

1 reference

Treatment of hypertension in patients 80 years of age or older

21 January 2018

1 reference

Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk

21 January 2018

1 reference

The cardioprotective effects of the angiotensin-converting enzyme inhibitor perindopril in patients with stable coronary artery disease are not modified by mild to moderate renal insufficiency: insights from the EUROPA trial

21 January 2018

1 reference

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials

21 January 2018

1 reference

Pathophysiologic and therapeutic importance of tissue ACE: a consensus report

21 January 2018

1 reference

Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease

21 January 2018

1 reference

Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies

21 January 2018

1 reference

Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients

21 January 2018

1 reference

Safety profile of perindopril

21 January 2018

1 reference

Pharmacogenetics of ACE inhibition in stable coronary artery disease: steps towards tailored drug therapy

21 January 2018

1 reference

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial

21 January 2018

1 reference

ACE inhibition with perindopril and endothelial function. Results of a substudy of the EUROPA study: PERTINENT

21 January 2018

1 reference

Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE

21 January 2018

1 reference

Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin system

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERC.09.2

1 reference

20 August 2017

1 reference